[Health Resources and Services Administration](https://www.hrsa.gov)

June 2026 (Full application deadline, projected)

Up to $2,900,000 total; one award anticipated; project period and annual amounts not specified.

Supports a center to reduce illness and death from Hereditary Hemorrhagic Telangiectasia (HHT) through improved care access, clinician support, and a patient data registry.

--- ## Description This program aims to reduce morbidity and mortality associated with Hereditary Hemorrhagic Telangiectasia (HHT), a rare genetic disorder. The funded center will work collaboratively to expand access and coordination of care, develop innovative approaches to help clinicians identify and diagnose HHT cases, and establish a de-identified, aggregate patient data registry to improve understanding of the disease and treatment outcomes. The program is structured as a cooperative agreement, emphasizing partnership between the awardee and the Health Resources and Services Administration (HRSA). --- ## Due Dates - June 2026 (Full application deadline, anticipated/projected) *All dates are projected based on the annual cycle; check the program page for updates.* --- ## Funding Amount - Estimated total program funding: $2,900,000 - Award ceiling: $2,900,000 (maximum per award) - Award floor: $0 - Expected number of awards: 1 - Project period and annual breakdown not specified Cost sharing or matching is **not required**. --- ## Eligibility - Eligible applicants include: - State governments - Unrestricted: Any entity, subject to clarification below - Additional eligibility: - Applicants must be "domestic," defined as entities located in the 50 states, District of Columbia, Puerto Rico, Northern Mariana Islands, American Samoa, Guam, U.S. Virgin Islands, Federated States of Micronesia, Republic of the Marshall Islands, and Republic of Palau. --- ## Application Process - This is a forecasted opportunity; the Notice of Funding Opportunity (NOFO) is not yet released. - Applications will be submitted electronically via [Grants.gov](https://www.grants.gov/search-results-detail/361511) once the application period opens. - Review the HRSA program page for the latest updates and application instructions as the forecasted date approaches. --- ## Additional Information - The program is a cooperative agreement, indicating substantial involvement from HRSA in project execution. - Focus areas: expanding clinical care access, clinician support for HHT identification/diagnosis, and data registry development. - Only one award is anticipated; applicants should demonstrate capacity for national coordination and data management. --- ## External Links - [Opportunity Forecast and Application Instructions (Grants.gov)](https://www.grants.gov/search-results-detail/361511) - [Health Resources and Services Administration (HRSA) Home](https://www.hrsa.gov) - [HRSA Contact Page](https://www.hrsa.gov/about/contact) --- ## Contact Information | Name | Email | Phone | |-----------------|-------------------------------|--------------| | Nordia Williams | [nwilliams1@hrsa.gov](mailto:nwilliams1@hrsa.gov) | 240-475-3310 |

Hereditary Hemorrhagic Telangiectasia (HHT) Center

Sign in to see full grant listing